Substandard drugs: a potential crisis for public health.
about
Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimodCounterfeit medicines in Peru: a retrospective review (1997-2014)Chronic kidney disease in low- and middle-income countriesQuantitative bioassay to identify antimicrobial drugs through drug interaction fingerprint analysis.Antiretroviral therapy supply chain quality control and assurance in improving people living with HIV therapeutic outcomes in Cameroon.Identification of Substandard Medicines via Disproportionality Analysis of Individual Case Safety Reports.Isoniazid: A Review of Characteristics, Properties and Analytical Methods.The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians.Operation resistance: A snapshot of falsified antibiotics and biopharmaceutical injectables in Europe.Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy.The Influence of Emerging Markets on the Pharmaceutical Industry.The Quality of Medicines Used in Children and Supplied by Private Pharmaceutical Wholesalers in Kinshasa, Democratic Republic of Congo: A Prospective Survey.Advancing pharmaceuticals and patient safety in Saudi Arabia: A 2030 vision initiative.Medicines quality assurance to fight antimicrobial resistance.Perceptions of the quality of generic medicines: implications for trust in public services within the local health system in Tumkur, India.The Belgian commitment to pharmaceutical quality: a model policy to improve quality assurance of medicines available through humanitarian and development programs.Global landscape assessment of screening technologies for medicine quality assurance: stakeholder perceptions and practices from ten countries.Pharmaceutical quality assurance of local private distributors: a secondary analysis in 13 low-income and middle-income countries.Quality of medicines in resource-limited settings: need for ethical guidanceQuality of medicines: Deficiencies found by Brazilian Health Regulatory Agency (ANVISA) on good manufacturing practices international inspections
P2860
Q26740235-148DEEC2-0FB2-45DA-AD39-2EC6E3663A56Q36773192-5496C470-AE13-479E-BAE0-19389ED0C5E3Q36926927-38E762AC-DD9B-4395-A8BF-F82EEC40A2CDQ37644385-94440169-000A-4FA8-B20C-9C40DACECCE0Q37736858-62A42A4C-E70B-4CE1-8121-C749890F269FQ38994263-C8AC4F1D-F8A9-40C7-B04C-BAC6A5BF8A12Q39083469-2A12F842-F5CA-4DCA-B44C-9E06F4A10158Q40322708-FC3EBDAC-8BBE-4DA9-A6D3-69ACE5ABD871Q40957693-6A1B6AFB-4896-41A3-A63D-58C490AFC34BQ42370094-E56421AE-621A-413F-8F5C-C47B5D209F43Q47101436-964F168E-519A-4CDB-B5D4-81B1F69B9B05Q48521945-51E52425-B4CF-497E-B0A6-BBB52B7D8265Q49260603-BF328F8F-B9C3-4644-93DB-CBFDD0445FFCQ49295066-4B2842AB-7A24-4DE4-8866-E3C25A34E9F2Q53435677-957E7962-83A8-41D1-A401-F1113AA9FB83Q55018359-3EFBCFEC-2EF8-4C75-B709-09C93180ED03Q55035189-2F115334-415E-4898-AC33-334E288BBB99Q55422283-E59E2B82-65D6-4CB9-862B-3628CF26826BQ58657032-F005413A-D0FD-4559-B744-65AFF259B1F2Q58796183-F73D58CF-345D-4C9E-B6AF-2DEC38DA6B0B
P2860
Substandard drugs: a potential crisis for public health.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Substandard drugs: a potential crisis for public health.
@ast
Substandard drugs: a potential crisis for public health.
@en
Substandard drugs: a potential crisis for public health.
@nl
type
label
Substandard drugs: a potential crisis for public health.
@ast
Substandard drugs: a potential crisis for public health.
@en
Substandard drugs: a potential crisis for public health.
@nl
prefLabel
Substandard drugs: a potential crisis for public health.
@ast
Substandard drugs: a potential crisis for public health.
@en
Substandard drugs: a potential crisis for public health.
@nl
P2860
P356
P1476
Substandard drugs: a potential crisis for public health
@en
P2093
David W Holt
P2860
P304
P356
10.1111/BCP.12298
P407
P577
2014-08-01T00:00:00Z